Stay updated on Subcutaneous Lirentelimab in Urticaria: Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision label changed from v3.5.4 to v3.5.5. This indicates a minor update to the page template or content without altering the study information.
    Difference
    0.0%
    Check dated 2026-06-05T22:11:38.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, indicating a small backend update to the page without changes to the study information presented.
    Difference
    0.0%
    Check dated 2026-05-15T15:39:44.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page’s revision/version indicator in the footer has been updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the study record details.
    Difference
    0.0%
    Check dated 2026-04-24T06:22:45.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-17T02:45:08.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The page metadata now shows Revision: v3.5.0, replacing Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T05:13:06.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T00:47:56.000Z thumbnail image

Stay in the know with updates to Subcutaneous Lirentelimab in Urticaria: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page.